Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarida Alves

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
Journal of Clinical and Experimental Dentistry|November 24, 2017
Comparative analysis of impacted upper canines: Panoramic radiograph Vs Cone Beam Computed TomographyCatarina-Luís-Vicente-Rodrigues Pico, Francisco-José-Fernandes do Vale, Francisco-José-Santiago-Fernandes-Amado Caramelo, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|December 11, 2025
Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary centerMichael Colwill, Jessica Padley, Umang Qazi, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|July 15, 2021
Microbial communities associated with honey bees in Brazil and in the United StatesDenise de Oliveira Scoaris, Frederic Mendes Hughes, Milton Adolfo Silveira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.
BMC Rheumatology|May 22, 2024
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritisJeffrey A Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Neurobiology of Aging|August 16, 2016
Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutationJose Bras, Ruth Djaldetti, Ana Margarida Alves, et al.
The Saudi Dental Journal|November 22, 2021
Bioactive toothpastes in dentin hypersensitivity treatment: A systematic reviewSamantha Ariadne Alves de Freitas, Neurinéia Margarida Alves de Oliveira, Juliana Larocca de Geus, et al.
Rheumatology (Oxford, England)|May 31, 2022
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung diseaseMichael Kreuter, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
Journal of Clinical and Experimental Dentistry|November 24, 2017
Comparative analysis of impacted upper canines: Panoramic radiograph Vs Cone Beam Computed TomographyCatarina-Luís-Vicente-Rodrigues Pico, Francisco-José-Fernandes do Vale, Francisco-José-Santiago-Fernandes-Amado Caramelo, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|December 11, 2025
Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary centerMichael Colwill, Jessica Padley, Umang Qazi, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|July 15, 2021
Microbial communities associated with honey bees in Brazil and in the United StatesDenise de Oliveira Scoaris, Frederic Mendes Hughes, Milton Adolfo Silveira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.
BMC Rheumatology|May 22, 2024
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritisJeffrey A Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Neurobiology of Aging|August 16, 2016
Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutationJose Bras, Ruth Djaldetti, Ana Margarida Alves, et al.
The Saudi Dental Journal|November 22, 2021
Bioactive toothpastes in dentin hypersensitivity treatment: A systematic reviewSamantha Ariadne Alves de Freitas, Neurinéia Margarida Alves de Oliveira, Juliana Larocca de Geus, et al.
Rheumatology (Oxford, England)|May 31, 2022
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung diseaseMichael Kreuter, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, et al.
Pageof 6